Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GlaxoSmithKline
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Amgen
Eli Lilly and Company
Hoffmann-La Roche
Pfizer
Pfizer
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
AstraZeneca
ArriVent BioPharma, Inc.
Achieve Life Sciences
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
George Washington University
Genmab
Alliance for Clinical Trials in Oncology
Taiho Oncology, Inc.
NRG Oncology
NRG Oncology
NRG Oncology
NRG Oncology
Merck Sharp & Dohme LLC
Vergent Bioscience, Inc.
Nuvalent Inc.
M.D. Anderson Cancer Center
Seagen Inc.
Revolution Medicines, Inc.
Hoffmann-La Roche
City of Hope Medical Center
Merck Sharp & Dohme LLC
BioNTech SE
Roswell Park Cancer Institute
EMD Serono
Ottawa Hospital Research Institute
AstraZeneca
Alliance for Clinical Trials in Oncology
University Hospital, Brest
Avistone Biotechnology Co., Ltd.
National Cancer Institute (NCI)
AstraZeneca
Qilu Pharmaceutical Co., Ltd.